Dr Baker reviews the findings of his recent research into the association of interstitial lung disease among patients with rheumatoid arthritis who have been treated with both biologic and targeted disease-modifying antirheumatic drugs.

Matthew Baker, MD, on Interstitial Lung Disease Among Patients With RA Treated with DMARDs

The Rheumatology and Arthritis Learning Network is an online resource for the latest developments in rheumatology practice, providing a customized experience for users to stay informed about the topics that matter most to them, including rheumatoid arthritis, lupus, and osteoporosis.

Share Matthew Baker, MD, on Interstitial Lung Disease Among Patients With RA Treated with DMARDs

Sign up to save your podcasts

Matthew Baker, MD, on Interstitial Lung Disease Among Patients With RA Treated with DMARDs

Matthew Baker, MD, on Interstitial Lung Disease Among Patients With RA Treated with DMARDs

More shows like Rheumatology & Arthritis Learning Network

Rheumatology For The Royal College